Phenogenomic characterization of immunomodulatory purinergic signaling in glioblastoma.

被引:0
|
作者
Coy, Shannon [1 ]
Lin, Jia-Ren [1 ]
Wang, Shu [1 ]
Stopka, Sylwia [2 ]
Rashid, Rumana [3 ]
Hwang, Jaeho [4 ]
Khadka, Prasidda [5 ]
Euskirchen, Philipp [6 ]
Bandopadhayay, Pratiti [5 ]
Wen, Patrick Y. [5 ]
Sorger, Peter K. [1 ]
Agar, Nathalie [2 ]
Ligon, Keith L. [7 ]
Touat, Mehdi [8 ]
Santagata, Sandro [2 ]
机构
[1] Harvard Med Sch, Boston, MA 02115 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[4] Johns Hopkins Univ, Baltimore, MD USA
[5] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Charite Univ Med Berlin, Berlin, Germany
[7] Harvard Med Sch, Brigham & Womens Hosp, Dana, Boston, MA 02115 USA
[8] La Pitie Salpetriere Charles Foix Univ Hosp, Paris, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1816
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Venous thrombotic events in patients with glioblastoma.
    D'Alpium Santos Costa, Diogo D'Agoretta
    Romeira, Daniel
    Valente, Mariana Fernandes
    Passos, Joao
    Esteves, Susana
    Mayer, Alexandra
    Azevedo, Ana
    Marques, Jose Bravo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Characterization of the immune profile of cancer stem cells isolated from human glioblastoma.
    Maccalli, Cristina
    Mazzoleni, Stefania
    Scaramuzza, Samantha
    Sovena, Gloria
    Ferrone, Soldano
    Rossella, Galli
    Parmiani, Giorgio
    CANCER RESEARCH, 2009, 69
  • [23] An anatomic proteomic atlas of human glioblastoma.
    Lam, K. H. Brian
    Djuric, Ugljesa
    Batruch, Ihor
    Richer, Maxime
    Diamandis, Phedias
    CANCER RESEARCH, 2021, 81 (13)
  • [24] Efficacy and safety of selinexor in recurrent glioblastoma.
    Lassman, Andrew B.
    Wen, Patrick Y.
    Van den Bent, Martin J.
    Plotkin, Scott Randall
    Walenkamp, Anna Maria Elisabeth
    Huang, Xiu
    Rodriguez-Lopez, Karla
    Kauffman, Michael G.
    Shacham, Sharon
    Mau-Sorensen, Morten
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [25] Prognostic nomogram in elderly patients with glioblastoma.
    Patel, Mital
    Hashemi-Sadraei, Neda
    Elson, Paul
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] A NEUROENDOCRINE APPROACH IN THE TREATMENT OF BRAIN GLIOBLASTOMA.
    Porta, E.
    Messina, G.
    Porro, G.
    Lissoni, P.
    ANTICANCER RESEARCH, 2014, 34 (10) : 6118 - 6118
  • [27] Low platelet counts in patients with glioblastoma.
    Ali, Assad
    Barnett, Addisson
    Bamashmos, Anas Saeed
    Li, Hong
    Wei, Wei
    Sagar, Soumya
    Barnett, Gene H.
    Angelov, Lilyana
    Mohammadi, Alireza Mohammad
    Peereboom, David M.
    Stevens, Glen
    Suh, John H.
    Yu, Jennifer S.
    Murphy, Erin Sennett
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [28] The functional genomic landscape of recurrent glioblastoma.
    Chokshi, Chirayu
    Tieu, David
    Brown, Kevin
    Venugopal, Chitra
    Liu, Lina
    Kuhlman, Laura
    Chan, Katherine
    Tong, Amy
    Savage, Neil
    McKenna, Dillon
    Aghaei, Nikoo
    Subapanditha, Minomi
    Salamoun, Joseph M.
    Rossotti, Martin
    Wipf, Peter
    Sharlow, Elizabeth
    Lazo, John S.
    Kislinger, Thomas
    Henry, Kevin
    Lu, Yu
    Moffat, Jason
    Singh, Sheila K.
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (02)
  • [29] Aphasic hypergraphy in the course of a bihemispheric glioblastoma.
    Bailbé, M
    Pluchon, C
    Dumas, P
    Neau, JP
    Gil, R
    REVUE NEUROLOGIQUE, 2002, 158 (12) : 1198 - 1201
  • [30] CNS cancer: new options for glioblastoma.
    Errico A.
    Nature Reviews Clinical Oncology, 2014, 11 (3) : 124 - 124